麻豆传媒

Meta-analysis says anti-inflammatory relievers beat bronchodilators in reducing exacerbations

Significant reduction in hives and itch in antihistamine-resistant patients

Single infusion also reduced total plasma kallikrein protein levels versus placebo

Survey finds that 13% thought genetics were responsible, 27% blamed eating behaviors

Off-label use along with antihistamines improved activity, itch, and wheal count scores

Remibrutinib demonstrated superiority over placebo in both the REMIX-1 and -2 trials

No benefit for the privately insured in trial, but participants on Medicaid had lower risk

ChatGPT sometimes gave opposite answers, and clinicians themselves didn't always agree

In a survey, 42% of PCPs said they were "not familiar" with biologic therapies for asthma

Open-label extension of EPITOPE trial shows increased tolerance at 24 months

Patients taking the oral mucosal immunotherapy reported only minor adverse effects

Monoclonal antibodies, BTK inhibitor alleviate symptoms when antihistamines fall short

More kids had responses, decreased symptom severity, versus those who received placebo

Pharmacokinetics in healthy cohort looks promising